Upgrade to SI Premium - Free Trial

Lineage Cell Therapeutics (LCTX)

1.28 +0.05 (4.07%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Lineage Cell Therapeutics (LCTX) Misses Q1 EPS by 2c May 12, 2026 4:01 PM - StreetInsider Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update May 12, 2026 4:01 PM - BizWire Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026 May 5, 2026 8:00 AM - BizWire OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026 May 4, 2026 8:00 AM - BizWire Canaccord Starts Lineage Cell Therapeutics Inc. (LCTX) at Buy April 28, 2026 6:37 AM - StreetInsider Lineage Cell Therapeutics forms scientific advisory board April 13, 2026 8:02 AM - StreetInsider Lineage Announces Formation of Scientific Advisory Board April 13, 2026 8:00 AM - BizWire Lineage Cell Therapeutics Inc. (LCTX) PT Raised to $4 at B.Riley March 25, 2026 8:00 AM - StreetInsider Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease March 24, 2026 8:00 AM - BizWire Full Article List